Qiujing Wei

1.3k total citations
53 papers, 828 citations indexed

About

Qiujing Wei is a scholar working on Rheumatology, Immunology and Molecular Biology. According to data from OpenAlex, Qiujing Wei has authored 53 papers receiving a total of 828 indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Rheumatology, 22 papers in Immunology and 12 papers in Molecular Biology. Recurrent topics in Qiujing Wei's work include Spondyloarthritis Studies and Treatments (38 papers), Rheumatoid Arthritis Research and Therapies (17 papers) and Psoriasis: Treatment and Pathogenesis (14 papers). Qiujing Wei is often cited by papers focused on Spondyloarthritis Studies and Treatments (38 papers), Rheumatoid Arthritis Research and Therapies (17 papers) and Psoriasis: Treatment and Pathogenesis (14 papers). Qiujing Wei collaborates with scholars based in China, Australia and Netherlands. Qiujing Wei's co-authors include Jieruo Gu, Shuangyan Cao, Zetao Liao, Yutong Jiang, Jieruo Gu, Zhiming Lin, Xinwei Wang, Yefei Huang, Liudan Tu and Qing Lv and has published in prestigious journals such as PLoS ONE, Frontiers in Immunology and Annals of the Rheumatic Diseases.

In The Last Decade

Qiujing Wei

51 papers receiving 821 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qiujing Wei China 18 522 296 247 160 86 53 828
Gerasimos Evangelatos Greece 13 275 0.5× 178 0.6× 130 0.5× 114 0.7× 58 0.7× 37 567
Qiongyi Hu China 18 302 0.6× 402 1.4× 279 1.1× 418 2.6× 60 0.7× 57 843
Kaichi Kaneko Japan 14 153 0.3× 114 0.4× 160 0.6× 69 0.4× 118 1.4× 41 499
H. Richards United States 15 623 1.2× 864 2.9× 160 0.6× 187 1.2× 61 0.7× 44 1.1k
Jessica McHugh United States 9 217 0.4× 202 0.7× 176 0.7× 75 0.5× 31 0.4× 126 533
Raphael Micheroli Switzerland 13 513 1.0× 331 1.1× 80 0.3× 158 1.0× 32 0.4× 51 662
Eleonora Ballanti Italy 12 266 0.5× 357 1.2× 90 0.4× 121 0.8× 77 0.9× 18 649
Zoltán Szekanecz Hungary 12 279 0.5× 144 0.5× 88 0.4× 63 0.4× 59 0.7× 24 653
Ejaz Pathan United Kingdom 14 541 1.0× 369 1.2× 57 0.2× 175 1.1× 58 0.7× 28 737
Ana Barrera‐Vargas Mexico 15 233 0.4× 304 1.0× 142 0.6× 37 0.2× 42 0.5× 39 577

Countries citing papers authored by Qiujing Wei

Since Specialization
Citations

This map shows the geographic impact of Qiujing Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiujing Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiujing Wei more than expected).

Fields of papers citing papers by Qiujing Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiujing Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiujing Wei. The network helps show where Qiujing Wei may publish in the future.

Co-authorship network of co-authors of Qiujing Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Qiujing Wei. A scholar is included among the top collaborators of Qiujing Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiujing Wei. Qiujing Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wei, Qiujing, et al.. (2023). Peripheral CD4+/CD8+ T cell composition distinct from healthy individuals is shared by ankylosing spondylitis and rheumatoid arthritis. International Journal of Rheumatic Diseases. 26(10). 2014–2023. 1 indexed citations
2.
Tu, Liudan, Xiaohong Wang, Qingcong Kong, et al.. (2022). Etanercept/celecoxib on improving MRI inflammation of active ankylosing spondylitis: A multicenter, open-label, randomized clinical trial. Frontiers in Immunology. 13. 967658–967658. 5 indexed citations
3.
Qi, Jun, Huiquan Wen, Liudan Tu, et al.. (2022). Quantification of Fat Metaplasia in the Sacroiliac Joints of Patients With Axial Spondyloarthritis by Chemical Shift-Encoded MRI: A Diagnostic Trial. Frontiers in Immunology. 12. 811672–811672. 7 indexed citations
4.
Huang, Yefei, Xinyu Wu, Yutong Jiang, et al.. (2021). Age-Specific Imbalance of Circulating Tfh Cell Subsets and Its Association With Gout-Targeted Kidney Impairment. Frontiers in Immunology. 11. 625458–625458. 5 indexed citations
5.
Jiang, Yutong, Mingcan Yang, Yanli Zhang, et al.. (2021). Dynamics of Adaptive Immune Cell and NK Cell Subsets in Patients With Ankylosing Spondylitis After IL-17A Inhibition by Secukinumab. Frontiers in Pharmacology. 12. 738316–738316. 13 indexed citations
6.
Wu, Xinyu, Jialing Wu, Qiujing Wei, et al.. (2021). Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis. Frontiers in Immunology. 12. 700570–700570. 26 indexed citations
7.
Si, Lei, Liudan Tu, Gang Chen, et al.. (2020). Evaluating Health Related Quality of Life in Older People at Risk of Osteoporotic Fracture: A Head-to-Head Comparison of the EQ-5D-5L and AQoL-6D. Social Indicators Research. 160(2-3). 809–824. 2 indexed citations
8.
Liang, Jing, Yutong Jiang, Yefei Huang, et al.. (2020). The comparison of dyslipidemia and serum uric acid in patients with gout and asymptomatic hyperuricemia: a cross-sectional study. Lipids in Health and Disease. 19(1). 31–31. 50 indexed citations
9.
Yang, Mingcan, Qing Lv, Qiujing Wei, et al.. (2020). TNF-α inhibitor therapy can improve the immune imbalance of CD4+ T cells and negative regulatory cells but not CD8+ T cells in ankylosing spondylitis. Arthritis Research & Therapy. 22(1). 149–149. 26 indexed citations
10.
Tu, Liudan, Zetao Liao, Yutong Jiang, et al.. (2020). Cost of Illness, Quality of Life, and Work Outcomes in Active Ankylosing Spondylitis Patients Treated With Adalimumab in China. Frontiers in Public Health. 8. 602334–602334. 6 indexed citations
11.
Xiao, Min, Qing Lv, Yanli Zhang, et al.. (2019). Spondyloarthritis Patients Suffer Increased Risk of Renal Complications Compared With General Population: A Retrospective Observational Study. Frontiers in Pharmacology. 10. 1073–1073. 3 indexed citations
12.
Li, Xin, Jie Pan, Hui Zhou, et al.. (2019). A multi-centre study for standardization of antinuclear antibody indirect immunofluorescence screening with automated system. Journal of Immunological Methods. 477. 112701–112701. 3 indexed citations
13.
14.
Zhang, Yanli, Zetao Liao, Qiujing Wei, et al.. (2016). A Genome-Wide SNP Linkage Analysis Suggests a Susceptibility Locus on 6p21 for Ankylosing Spondylitis and Inflammatory Back Pain Trait. PLoS ONE. 11(12). e0166888–e0166888. 2 indexed citations
15.
Zhang, Ping, et al.. (2015). Changes of serum levels of MMP-3, sRANKL, and OPG in juvenile-onset ankylosing spondylitis patients carrying different HLA-B27 subtypes. Clinical Rheumatology. 34(6). 1085–1089. 15 indexed citations
16.
Lin, Qu, Zetao Liao, Qiuxia Li, et al.. (2014). Higher Percentage of CD3+CD154+ T Lymphocytes Predicts Efficacy of TNF-α Inhibitors in Active Axial SpA Patients. Inflammation. 37(6). 2056–2061. 2 indexed citations
17.
Li, Qiuxia, et al.. (2014). MiR-27a Targets sFRP1 in hFOB Cells to Regulate Proliferation, Apoptosis and Differentiation. PLoS ONE. 9(3). e91354–e91354. 70 indexed citations
18.
Li, Chao, Jinxian Huang, Qiujing Wei, et al.. (2010). ERAP1Is Associated with Ankylosing Spondylitis in Han Chinese. The Journal of Rheumatology. 38(2). 317–321. 28 indexed citations
19.
Lin, Qu, Zhiming Lin, Jieruo Gu, et al.. (2009). Abnormal high-expression of CD154 on T lymphocytes of ankylosing spondylitis patients is down-regulated by etanercept treatment. Rheumatology International. 30(3). 317–323. 11 indexed citations
20.
Wang, Xinwei, Jinxian Huang, Zetao Liao, et al.. (2009). Single-nucleotide polymorphisms and expression of IL23R in Chinese ankylosing spondylitis patients. Rheumatology International. 30(7). 955–959. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gerasimos Evangelatos Breakdown of academic impact, for papers by Qiongyi Hu Breakdown of academic impact, for papers by Kaichi Kaneko Breakdown of academic impact, for papers by H. Richards Breakdown of academic impact, for papers by Jessica McHugh Breakdown of academic impact, for papers by Raphael Micheroli Breakdown of academic impact, for papers by Eleonora Ballanti Breakdown of academic impact, for papers by Zoltán Szekanecz Breakdown of academic impact, for papers by Ejaz Pathan Breakdown of academic impact, for papers by Ana Barrera‐Vargas
Rankless by CCL
2026